Biological Therapy Analysis & Statistics, March 2015

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

1-30 of about 600 reports

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints ...

  • Industries : Hospitality, Hospitality, Tourism, Tourism, Biopharmaceutical, Biotechnology, Pharmaceutical
  • Countries : World, Europe
PharmaPoint: Rheumatoid Arthritis - 5EU Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - 5EU Drug Forecast and Market Analysis to 2023

  • $ 6 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - 5EU Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Biopharmaceutical, Pharmaceutical, Biotechnology
  • Countries : Europe
Gene Therapy Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape

Gene Therapy Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape

  • $ 6 000
  • Industry report
  • January 2015
  • by Delve Insight

Summary DelveInsight’s Report: Gene Therapy Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene therapy ...

  • Industries : Biological Therapy
PharmaPoint: Rheumatoid Arthritis - US Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - US Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - US Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Pharmaceutical
  • Countries : United States
PharmaPoint: Rheumatoid Arthritis - Australia Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - Australia Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - Australia Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the ...

  • Industries : Pharmaceutical, Biopharmaceutical
  • Countries : Australia, Oceania
PharmaPoint: Rheumatoid Arthritis - China Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - China Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - China Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Pharmaceutical, Biopharmaceutical
  • Countries : China, Asia
PharmaPoint: Rheumatoid Arthritis - India Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - India Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - India Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Pharmaceutical, Biopharmaceutical
  • Countries : India, Asia
Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth

Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth

  • $ 4 995
  • Industry report
  • December 2014
  • by GBI Research

Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth Summary Increasingly Crowded Market for Second-Line Therapies Improving Treatment Options for Moderate-to-Severe Rheumatoid ...

  • Industries : Pharmaceutical, Pathology
  • Countries : World
IVD (In Vitro Diagnostic) Testing World Markets

IVD (In Vitro Diagnostic) Testing World Markets

  • $ 4 500
  • Industry report
  • January 2015
  • by TriMark Publications

In vitro diagnostic (IVD) testing is experiencing a revival fueled by a combination of technological improvements, cost pressures, reimbursement changes, rapid growth in molecular diagnostics and increasing ...

  • Industries : Diagnostics, Diagnostics, In Vitro Diagnostic, In Vitro Diagnostic, Medical Devices
  • Countries : World
Gene Therapy Oncology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

Gene Therapy Oncology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

  • $ 3 500
  • Industry report
  • January 2015
  • by Delve Insight

Summary DelveInsight’s Report: Gene Therapy Oncology Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene ...

  • Industries : Biological Therapy
Rituxan/Mabthera (rituximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Rituxan/Mabthera (rituximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Rituxan/Mabthera (rituximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the ...

  • Industries : Pharmaceutical, Biological Therapy, Pathology, Biotechnology
  • Countries : World
Gene Therapy Central Nervous System Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

Gene Therapy Central Nervous System Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

  • $ 3 000
  • Industry report
  • January 2015
  • by Delve Insight

Summary DelveInsight’s Report: Gene Therapy Central Nervous System Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain ...

  • Industries : Biological Therapy
Gene Therapy Ophthalmology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

Gene Therapy Ophthalmology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

  • $ 3 000
  • Industry report
  • January 2015
  • by Delve Insight

Summary DelveInsight’s Report: Gene Therapy Ophthalmology Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering ...

  • Industries : Biological Therapy
Gene Therapy Infectious Disease Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

Gene Therapy Infectious Disease Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

  • $ 3 000
  • Industry report
  • January 2015
  • by Delve Insight

Summary DelveInsight’s Report: Gene Therapy Infectious Disease Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering ...

  • Industries : Biological Therapy
Gene Therapy Metabolic Disorders Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

Gene Therapy Metabolic Disorders Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

  • $ 3 000
  • Industry report
  • January 2015
  • by Delve Insight

Summary DelveInsight’s Report: Gene Therapy Metabolic Disorders Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain ...

  • Industries : Biological Therapy
Gene Therapy Cardiovascular Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

Gene Therapy Cardiovascular Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

  • $ 3 000
  • Industry report
  • January 2015
  • by Delve Insight

Summary DelveInsight’s Report: Gene Therapy Cardiovascular Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering ...

  • Industries : Biological Therapy
Gene Therapy Hematological Disorders Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

Gene Therapy Hematological Disorders Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

  • $ 3 000
  • Industry report
  • January 2015
  • by Delve Insight

Summary DelveInsight’s Report: Gene Therapy Hematological Disorders Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain ...

  • Industries : Biological Therapy
Febrile Neutropenia Global Clinical Trials Review, H2, 2014

Febrile Neutropenia Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • December 2014
  • by Global Data

Febrile Neutropenia Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Febrile Neutropenia Global Clinical Trials Review, H2, 2014" provides data on the Febrile Neutropenia ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World
B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Global Markets Direct

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015’, provides an overview of the B-Cell Non-Hodgkin Lymphoma’s ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Leukodystrophies - Pipeline Review, H1 2015

Leukodystrophies - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Global Markets Direct

Leukodystrophies - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Leukodystrophies - Pipeline Review, H1 2015’, provides an overview of the Leukodystrophies’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Anal Cancer - Pipeline Review, H1 2015

Anal Cancer - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Global Markets Direct

Anal Cancer - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Anal Cancer - Pipeline Review, H1 2015’, provides an overview of the Anal Cancer’s therapeutic pipeline. This report provides ...

  • Industries : General Medicine and Specialty Medicine, Pathology, Pharmaceutical, Healthcare
  • Countries : United States, World
Batten Disease - Pipeline Review, H1 2015

Batten Disease - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Global Markets Direct

Batten Disease - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Batten Disease - Pipeline Review, H1 2015’, provides an overview of the Batten Disease’s therapeutic pipeline. This report ...

  • Industries : Pathology
  • Countries : United States
Growth Hormone Deficiency-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Growth Hormone Deficiency-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight’s, “Growth Hormone Deficiency-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

  • Industries : Hosting, Hosting
  • Countries : World, Europe, India, China
Epstein-Barr Viral Infections - Pipeline Review, H1 2015

Epstein-Barr Viral Infections - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Epstein-Barr Viral Infections - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Epstein-Barr Viral Infections - Pipeline Review, H1 2015’, provides an overview of the Epstein-Barr Viral ...

  • Industries : Pathology, Research and Development, Pharmaceutical, Biopharmaceutical, General Medicine and Specialty Medicine, Biological Therapy
  • Countries : United States
Metastatic Melanoma - Pipeline Review, H1 2015

Metastatic Melanoma - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Metastatic Melanoma - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Metastatic Melanoma - Pipeline Review, H1 2015’, provides an overview of the Metastatic Melanoma’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H1 2015

Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline ...

  • Industries : Pharmaceutical, Pathology
  • Countries : United States
Venous Leg Ulcers (Crural ulcer) - Pipeline Review, H1 2015

Venous Leg Ulcers (Crural ulcer) - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Venous Leg Ulcers (Crural ulcer) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Venous Leg Ulcers (Crural ulcer) - Pipeline Review, H1 2015’, provides an overview of the Venous Leg ...

  • Industries : Medical Equipment and Supply
  • Countries : United States
Acute Spinal Cord Injury - Pipeline Review, H1 2015

Acute Spinal Cord Injury - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Acute Spinal Cord Injury - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Acute Spinal Cord Injury - Pipeline Review, H1 2015’, provides an overview of the Acute Spinal Cord Injury’s ...

  • Industries : Pathology
  • Countries : United States
Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2015

Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Pharmaceutical
  • Countries : United States
Vasculitis - Pipeline Review, H1 2015

Vasculitis - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Vasculitis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Vasculitis - Pipeline Review, H1 2015’, provides an overview of the Vasculitis’s therapeutic pipeline. This report provides ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.